Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Endeavour Mng Plc (EDVMF)

Endeavour Mng Plc (EDVMF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Siskinds LLP announces investigation into Endeavour Mining plc.

/CNW/ - Siskinds LLP is investigating potential shareholder claims against Endeavour Mining plc (TSX: EDV) (LSE: EDV) (OTXCQ: EDVMF) ("Endeavour Mining") and...

EDV.TO : 86.03 (+4.04%)
EDVMF : 62.5000 (+1.79%)
EDV.LN : 4,702.000 (+4.26%)
INVESTIGATION ALERT: Berger Montague is Investigating Securities Fraud Claims on Behalf of Endeavour Mining plc (OTC: EDVMF; TSX: EDV) Investors

/CNW/ -- Berger Montague, with offices in Canada and throughout the United States, is currently investigating potential violations of the federal securities...

EDV.TO : 86.03 (+4.04%)
EDVMF : 62.5000 (+1.79%)
Gold and The New World Order

For thousands of years, gold has been a safe haven in times of turbulence, and that is no less true today. Some investors are well aware of this and are piling into gold as a new world order - mistrust...

SGOL : 47.49 (+2.19%)
EDVMF : 62.5000 (+1.79%)
GCQ23 : 1,936.5s (+0.97%)
GLD : 458.28 (+2.25%)

Barchart Exclusives

Moderna Jumps Above 20-Day Moving Average on FDA Flu Vaccine Review. Should You Buy MRNA Stock Here?
Moderna shares extend gains as FDA reverses its refusal-to-file decision on the firm’s influenza vaccine. Here’s why MRNA shares still aren’t attractive to own in 2026. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar